129 related articles for article (PubMed ID: 32467984)
1. Characterization of KIF20A as a prognostic biomarker and therapeutic target for different subtypes of breast cancer.
Nakamura M; Takano A; Thang PM; Tsevegjav B; Zhu M; Yokose T; Yamashita T; Miyagi Y; Daigo Y
Int J Oncol; 2020 Jul; 57(1):277-288. PubMed ID: 32467984
[TBL] [Abstract][Full Text] [Related]
2. Aberrantly activated Gli2-KIF20A axis is crucial for growth of hepatocellular carcinoma and predicts poor prognosis.
Shi C; Huang D; Lu N; Chen D; Zhang M; Yan Y; Deng L; Lu Q; Lu H; Luo S
Oncotarget; 2016 May; 7(18):26206-19. PubMed ID: 27036048
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients.
Liu SL; Lin HX; Qiu F; Zhang WJ; Niu CH; Wen W; Sun XQ; Ye LP; Wu XQ; Lin CY; Song LB; Guo L
PLoS One; 2017; 12(1):e0169280. PubMed ID: 28081138
[TBL] [Abstract][Full Text] [Related]
4. KIF20A, highly expressed in immature hematopoietic cells, supports the growth of HL60 cell line.
Morita H; Matsuoka A; Kida JI; Tabata H; Tohyama K; Tohyama Y
Int J Hematol; 2018 Dec; 108(6):607-614. PubMed ID: 30182171
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis.
Zhao X; Zhou LL; Li X; Ni J; Chen P; Ma R; Wu J; Feng J
Cancer Med; 2018 Sep; 7(9):4678-4689. PubMed ID: 30105795
[TBL] [Abstract][Full Text] [Related]
6. KIF20A expression as a prognostic indicator and its possible involvement in the proliferation of ovarian clear‑cell carcinoma cells.
Kawai Y; Shibata K; Sakata J; Suzuki S; Utsumi F; Niimi K; Sekiya R; Senga T; Kikkawa F; Kajiyama H
Oncol Rep; 2018 Jul; 40(1):195-205. PubMed ID: 29749467
[TBL] [Abstract][Full Text] [Related]
7. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
[TBL] [Abstract][Full Text] [Related]
8. Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma.
Lu M; Huang X; Chen Y; Fu Y; Xu C; Xiang W; Li C; Zhang S; Yu C
IUBMB Life; 2018 Apr; 70(4):328-335. PubMed ID: 29500859
[TBL] [Abstract][Full Text] [Related]
9. Kinesin family member 11 is a potential therapeutic target and is suppressed by microRNA-30a in breast cancer.
Wang B; Yu J; Sun Z; Luh F; Lin D; Shen Y; Wang T; Zhang Q; Liu X
Mol Carcinog; 2020 Aug; 59(8):908-922. PubMed ID: 32346924
[TBL] [Abstract][Full Text] [Related]
10. Cyclin F and KIF20A, FOXM1 target genes, increase proliferation and invasion of ovarian cancer cells.
Li Y; Guo H; Wang Z; Bu H; Wang S; Wang H; Fang H; Liu Z; Kong B
Exp Cell Res; 2020 Oct; 395(2):112212. PubMed ID: 32771525
[TBL] [Abstract][Full Text] [Related]
11. KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells.
Shen T; Yang L; Zhang Z; Yu J; Dai L; Gao M; Shang Z; Niu Y
Dis Markers; 2019; 2019():4863182. PubMed ID: 31093305
[TBL] [Abstract][Full Text] [Related]
12. Distinct Diagnostic and Prognostic Values of Kinesin Family Member Genes Expression in Patients with Breast Cancer.
Song X; Zhang T; Wang X; Liao X; Han C; Yang C; Su K; Cao W; Gong Y; Chen Z; Han Q; Li J
Med Sci Monit; 2018 Dec; 24():9442-9464. PubMed ID: 30593585
[TBL] [Abstract][Full Text] [Related]
13. Kif20a inhibition reduces migration and invasion of pancreatic cancer cells.
Stangel D; Erkan M; Buchholz M; Gress T; Michalski C; Raulefs S; Friess H; Kleeff J
J Surg Res; 2015 Jul; 197(1):91-100. PubMed ID: 25953216
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of KIF20A, a potential immunotherapeutic target for glioma.
Saito K; Ohta S; Kawakami Y; Yoshida K; Toda M
J Neurooncol; 2017 Mar; 132(1):63-74. PubMed ID: 28070829
[TBL] [Abstract][Full Text] [Related]
15. Genistein-induced mitotic arrest of gastric cancer cells by downregulating KIF20A, a proteomics study.
Yan GR; Zou FY; Dang BL; Zhang Y; Yu G; Liu X; He QY
Proteomics; 2012 Aug; 12(14):2391-9. PubMed ID: 22887948
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of KIF20A promotes tumor proliferation and invasion in renal clear cell carcinoma and is associated with adverse clinical outcome.
Ren X; Chen X; Ji Y; Li L; Li Y; Qin C; Fang K
Aging (Albany NY); 2020 Nov; 12(24):25878-25894. PubMed ID: 33232285
[TBL] [Abstract][Full Text] [Related]
17. Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.
Alfarsi LH; Elansari R; Toss MS; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2019 Jan; 173(1):93-102. PubMed ID: 30306428
[TBL] [Abstract][Full Text] [Related]
18. Kinesin family member 20A is a novel melanoma-associated antigen.
Yamashita J; Fukushima S; Jinnin M; Honda N; Makino K; Sakai K; Masuguchi S; Inoue Y; Ihn H
Acta Derm Venereol; 2012 Nov; 92(6):593-7. PubMed ID: 22854760
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial measurement of CDKN1A/p21 and KIF20A expression for discrimination of DNA damage-induced clastogenicity.
Sakai R; Morikawa Y; Kondo C; Oka H; Miyajima H; Kubo K; Uehara T
Int J Mol Sci; 2014 Sep; 15(10):17256-69. PubMed ID: 25264741
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of
Zhu Z; Jin Z; Zhang H; Zhang M; Sun D
J Cancer; 2020; 11(17):5088-5098. PubMed ID: 32742456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]